Vanda Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Vanda Pharmaceuticals Inc. is developing treatments for schizophrenia by rescuing previously discontinued compounds and developing them into individualized therapeutics through the use of pharmacogenomics and pharmacogenetics.